In addition to its effects on sympathetic neurons, AP-2β has been demonstrated to enhance retinoic acid (RA) responsiveness, which potentiates neuronal differentiation and therefore is used in neuroblastoma therapy [33]. This evidence concerns the gene TFAP2B and neuroblastoma.